$ACET
Adicet Bio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
ACET chart
What traders are saying about $ACET
Latest postsAdicet Bio, Inc. news
- Two passive holders each report more than 5% ownership in Adicet Bio (ACET).
Stock Titan ·
- Advanced Renal Cell Carcinoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
StreetInsider ·
- Adicet Bio to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- Adicet Bio’s Prula-Cel Delivers 54% Lupus Remission Rate at 12 Months
marketbeat.com ·
- Adicet Bio Reports Positive Prula-cel Phase 1 Lupus Data as Pivotal Study Plans Advance
investorshub.advfn.com ·
- Is Tenet Healthcare (THC) Outperforming Other Medical Stocks This Year?
Yahoo Finance ·
- Adicet Bio Reports Phase 1 Prula-cel Data in Lupus Patients
investorshub.advfn.com ·
- Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
Yahoo Finance ·
- Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
Yahoo Finance ·
- Wall Street Analysts See a 258.21% Upside in Adicet Bio (ACET): Can the Stock Really Move This High?
Yahoo Finance ·
- Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year?
Yahoo Finance ·
- Adicet Bio to Participate in Fireside Chat at H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
Adicet Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$116.8M | -$117.1M | -$142.7M | -$69.8M |
| Diluted EPS | $-16.95 | $-21.33 | $-3.31 | $-1.70 |
| Total assets (year end) | $192.4M | $220.2M | $207.3M | $330.7M |
| Cash and equivalents (year end) | $38.9M | $56.5M | $159.7M | $257.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Adicet Bio, Inc.
- Ticker
- ACET (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 26
- SEC CIK
- 1720580
- Former names
- resTORbio, Inc.
Frequently asked questions
What exchange is Adicet Bio, Inc. listed on?
Adicet Bio, Inc. trades on the Nasdaq under the ticker symbol ACET.
What industry is Adicet Bio, Inc. in?
Adicet Bio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Adicet Bio, Inc. headquartered?
Adicet Bio, Inc.'s business address on file with the SEC is in Boston, MA.
When does Adicet Bio, Inc.'s fiscal year end?
Adicet Bio, Inc.'s fiscal year ends on December 26.